HORII Ikuo | Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
スポンサーリンク
概要
関連著者
-
HORII Ikuo
Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
Horii Ikuo
Showa Univ. (department Of Biochemical Toxicology School Of Pharmaceutical Sciences)
-
Horii Ikuo
Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Horii Ikuo
Worldwide Safety Sciences Pgrd Nagoya Laboratories Pfizer Inc.
-
Horii Ikuo
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Horii Ikuo
Biochemical Toxicology School Of Pharmaceutical Sciences Showa University
-
Kobayashi Kazuko
Research Compliance & Quality Assurance Coordination Department Research Division Chugai Pharmac
-
SHINDOH Hidetoshi
Pre-clinical Research Department
-
KAWASHIMA Akira
Safety Assessment Department
-
SHISHIDO Nobuyuki
Safety Assessment Department
-
NAKANO Kounosuke
Pre-clinical Research Department
-
Horii Ikuo
Pfizer Global Research And Development Worldwide Safety Sciences
-
Nakano Kohnosuke
Pre-clinical Research Department Research Division Chugai Pharmaceutical Co. Ltd.
-
Nakano Kounosuke
Pre-clinical Research Department Research Division Chugai Pharmaceutical Co. Ltd. Fuji Gotemba Resea
-
Shishido Nobuyuki
Safety Assessment Department Research Division Chugai Pharmaceutical Co. Ltd.
-
Shishido Nobuyuki
Safety Assessment Department Research Division Chugai Pharmaceutical Co. Ltd. Fuji Gotemba Research
-
Shindoh Hidetoshi
Department Of Toxicology And Pathology Department Of Pharmacokinetics And Metabolism Nippon Roche Re
-
Kobayashi Kazuko
Research Compliance & Quality Assurance Coordination Department Research Division Chugai Pharmac
-
Kawashima Akira
Department Of Toxicology And Pathology Department Of Pharmacokinetics And Metabolism Nippon Roche Re
-
Shindoh Hidetoshi
Pre-clinical Res. Dep. Res. Div. Chugai Pharmaceutical Co. Ltd. Kamakura Res. Labs.
-
Horii I
Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
-
Tomizawa Kaori
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
Yamada Hiroshi
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
Hamada Y.
Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
-
TOMIZAWA KAORI
Pfizer WW Safety Sciences-Nagoya
-
YAMADA HIROSHI
Pfizer WW Safety Sciences-Nagoya
-
Horii Ikuo
Pfizer Global Research And Development Nagoya Laboratories Drug Safety Evaluation
著作論文
- EFFECT OF DOSE REGIMEN ON THE TOXICITY OF 2'-DEOXY-2'-METHYLIDENECYTIDINE (DMDC) IN MONKEYS
- RELATIONSHIP BETWEEN AUC of 5'-DFUR AND TOXICITY OF CAPECITABINE, FLUOROPYRIMIDINE CARBAMATE ANALOGS, AND 5'-DFUR IN MONKEYS, MICE, AND RATS
- Current Status and Future Aspects of Toxicological Biomarkers in Safety Evaluation(EDUCATIONAL LECTURES, Proceedings of the 32nd Annual Meeting)
- Toxicologist Certification and IART (International Assembly for the Recognition of Toxicologists)(Qualification test system and international situation, Proceedings of the 32nd Annual Meeting)
- Toxicological Evaluation in Pediatric Drug Development lssues to Consider Regarding Pediatric Drug Development : How to Ensure Safety Evaluation of Pediatric Drug Products in Non-clinical Safety Studies(Breaking Through the Stage of Non-clinical to Clinic
- The use of gene expression profiling in rat hepatocyte cultures using adapter-tagged competitive PCR (TOXICOGENOMICS AND TOXICOPROTEOMICS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Molecular Toxicological Approach in Drug Discovery and Development(WORKSHOP 3 : TOXICOGENOMICS AND MOLECULAR TOXICOLOGY)